PATENT CLAIM ANALYSIS

Application Number: 16241954
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "400000"]

Abstract:
Described herein are polymeric drug-carrying nanogels that are capable of targeting to P-selectin for the treatment of cancer and other diseases and conditions associated with P-selectin. Furthermore, in certain embodiments, the nanogels presented here offer a drug release mechanism based on acidic pH in the microenvironment of a tumor, thereby providing improved treatment targeting capability and allowing use of lower drug doses, thereby reducing toxicity.

Claim (Index 15):
The method of  claim 13 , wherein the P-selectin associated disease comprises a member selected from the group consisting of carcinoma, sarcoma, lymphoma, leukemia, sickle cell disease, arterial thrombosis, rheumatoid arthritis, ischemia, and reperfusion.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.39216
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15069311', '14526660', '15470169', '15752008', '12997983']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.670307057054893
- 35 USC 102 Novelty (BERT): 0.6230590670173171
- Combined Prediction Score: 0.6655822580511355
- Mean Citation Score: 296.038546
- Max Citation Score: 614.23975
- Similarity Product: 488.1771674792617

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test